
About Bravit Pharmaceuticals Private Limited
Data last updated:
Bravit Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India, recognised as a startup by DPIIT. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 25 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85300GJ2021PTC119775. Its GSTIN is 24AAJCB5912A1Z7 (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Roy Rajshree Ajay and Ajay Kumar Roy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ffo – 506 Sakar East Bs.Guru Nanak School Tarsali, Vadodara, Gujarat, India – 390009.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.64 Lakh, a growth of 69% compared to the previous year. For the same year it recorded a net loss of ₹7,000 (net margin -4.3%) and EBITDA of -₹7,000 (EBITDA margin -4.3%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years.
Bravit Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0018412). For more details, the company can be reached via its website bravitpharmaceutials.com.
Company details
Recognitions & Rankings of Bravit Pharmaceuticals
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-GJ-24-0018412
Contact details
Bravit Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is bravitpharmaceutials.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFfo – 506 Sakar East Bs.Guru Nanak School Tarsali, Vadodara, Gujarat, India – 390009
- IndustryE-Commerce, Online Healthcare Product Retail
To see the full contact details of Bravit Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bravit Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Bravit Pharmaceuticals Private Limited, buy the company report.
Financials of Bravit Pharmaceuticals Private Limited
FY 2025 filings availableBravit Pharmaceuticals Private Limited reported revenue of ₹1.64 Lakh (up 69% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 69% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.3% | ||||
| Net Profit Margin | -4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bravit Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bravit Pharmaceuticals Private Limited
Bravit Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Roy Rajshree Ajay Also directs: Bravit Healthcare LLP | Director | 25 Jan 2021 | 5 Years 9 Months | Current |
| Ajay Kumar Roy Also directs: Bravit Healthcare LLP | Director | 25 Jan 2021 | 5 Years 9 Months | Current |
| Nileshkumar Devendrabhai Vaghela | Additional Director | 23 Dec 2025 | 0 Years 10 Months | Current |
| Nileshkumar Jacobbhai Christi | Additional Director | 23 Dec 2025 | 0 Years 10 Months | Current |
Auditor
Bravit Pharmaceuticals Private Limited is audited by K R & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K R & ASSOCIATES | FY 2022 | 131846W |
Shareholding
The shareholding of Bravit Pharmaceuticals Private Limited is on record for FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Bravit Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bravit Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bravit Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bravit Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Bravit Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCB5912A1Z7 | Gujarat | Active | 11 Feb 2021 |
To see the full GST registrations and return filing status of Bravit Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bravit Pharmaceuticals Private Limited has 12 board changes on record since 2021: 8 appointments and 4 cessations. The latest: Nileshkumar Devendrabhai Vaghela was appointed as Additional Director on 23 Dec 2025.
3 earlier events are in the company report.
Frequently asked questions
Bravit Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 25 January 2021 (5+ years old) and is registered under CIN U85300GJ2021PTC119775.
Bravit Pharmaceuticals has 4 current directors:
- Roy Rajshree Ajay - Director
- Ajay Kumar Roy - Director
- Nileshkumar Devendrabhai Vaghela - Additional Director
- Nileshkumar Jacobbhai Christi - Additional Director
The latest financial statements of Bravit Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Bravit Pharmaceuticals is 24AAJCB5912A1Z7, registered in Gujarat.
The CIN (Corporate Identification Number) of Bravit Pharmaceuticals is U85300GJ2021PTC119775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bravit Pharmaceuticals was incorporated on 25 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Nileshkumar Devendrabhai Vaghela was appointed as Additional Director on 23 Dec 2025. Nileshkumar Jacobbhai Christi was appointed as Additional Director on 23 Dec 2025. Garima Rakesh Singla ceased to be Director on 11 Feb 2022. Bravit Pharmaceuticals has 12 board changes on record in total.
Yes, Bravit Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Bravit Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0018412).
Bravit Pharmaceuticals can be reached through the website bravitpharmaceutials.com. Its registered office is in Vadodara, Gujarat, India.

